Ghost Tree Capital’s Edwards Lifesciences EW Stock Holding History

Ghost Tree Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-255,000	Closed	-$10.2M	–	79
2016 Q3	$10.2M	Hold	255,000	–	–	1.66%	19
2016 Q2	$8.48M	Buy	+255,000	New	+$8.72M	2.45%	10
2015 Q4	–	Sell	-240,000	Closed	-$5.69M	–	57
2015 Q3	$5.69M	Buy	+240,000	New	+$5.79M	2.56%	13
2014 Q4	–	Sell	-150,000	Closed	-$2.55M	–	71
2014 Q3	$2.55M	Buy	150,000 +30,000	+25%	+$474K	1.39%	35
2014 Q2	$1.72M	Sell	120,000 -60,000	-33%	-$813K	1.21%	30
2014 Q1	$2.23M	Buy	+180,000	New	+$2.08M	1.32%	27

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ghost Tree Capital's EW Position: Q4 2016 in Review

Ghost Tree Capital sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 255,000 shares — an estimated $10.2M sold.

Ghost Tree Capital first reported a position in EW in Q1 2014 and held it in 6 quarters. The position peaked at $10.2M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

Ghost Tree Capital reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
Ghost Tree Capital sold 255,000 Edwards Lifesciences shares in Q4 2016, an estimated $10.2M.
Ghost Tree Capital first reported a position in Edwards Lifesciences in Q1 2014 and held it in 6 quarters.
Ghost Tree Capital's Edwards Lifesciences position peaked at $10.2M in Q3 2016.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Ghost Tree Capital's 13F filing for Q4 2016, filed 14 Feb 2017.